FDA names Richard Pazdur its high drug regulator
WASHINGTON — The Meals and Drug Administration on Tuesday named Richard Pazdur, its longtime overseer of most cancers therapies, as high drug regulator .
Pazdur replaces former Heart for Drug Analysis and Analysis Director George Tidmarsh, who exited the company earlier this month amid accusations of utilizing his regulatory authority to advance a private vendetta in opposition to a former enterprise affiliate, and amid infighting with vaccine and biologics heart director Vinay Prasad.
“Dr. Pazdur is a real regulatory innovator who will assist information our broader agenda to modernize the company and streamline the approval course of,” mentioned FDA Commissioner Marty Makary in an announcement. “He has a observe file of success and is a powerful forward-thinking scientist.”
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
